Advertisement
Research Article| Volume 50, ISSUE 5, P454-458, July 2012

Efficacy of liposome-encapsulated 0.5% ropivacaine in maxillary dental anaesthesia

  • M. Franz-Montan
    Correspondence
    Corresponding author. Tel.: +55 19 35216144.
    Affiliations
    Department of Biochemistry, Institute of Biology, University of Campinas – UNICAMP, Cidade Universitária Zeferino Vaz, s/n, Barão Geraldo, Campinas, São Paulo CEP 13.083-970, Brazil

    Department of Physiological Sciences, Piracicaba Dental School, University of Campinas – UNICAMP, Piracicaba, São Paulo, Brazil
    Search for articles by this author
  • E. de Paula
    Affiliations
    Department of Biochemistry, Institute of Biology, University of Campinas – UNICAMP, Cidade Universitária Zeferino Vaz, s/n, Barão Geraldo, Campinas, São Paulo CEP 13.083-970, Brazil
    Search for articles by this author
  • F.C. Groppo
    Affiliations
    Department of Physiological Sciences, Piracicaba Dental School, University of Campinas – UNICAMP, Piracicaba, São Paulo, Brazil
    Search for articles by this author
  • J. Ranali
    Affiliations
    Department of Physiological Sciences, Piracicaba Dental School, University of Campinas – UNICAMP, Piracicaba, São Paulo, Brazil
    Search for articles by this author
  • M.C. Volpato
    Affiliations
    Department of Physiological Sciences, Piracicaba Dental School, University of Campinas – UNICAMP, Piracicaba, São Paulo, Brazil
    Search for articles by this author
Published:August 10, 2011DOI:https://doi.org/10.1016/j.bjoms.2011.07.010

      Abstract

      The aim of this study was to evaluate the effectiveness of liposome-encapsulated ropivacaine (0.5%) in dental anaesthesia. This randomised, double-blind, crossover, four-period treatment study included 40 volunteers who were given 1.8 ml of the following local anaesthetics into the buccal sulcus at the right level of the upper canine: 0.5% ropivacaine; 0.5% ropivacaine with 1:200,000 adrenaline; liposome-encapsulated 0.5% ropivacaine; and 2% lignocaine with 1:100,000 adrenaline. Onset of pulpal anaesthesia; the success of anaesthesia; and the duration of labial, gingival, and pulpal anaesthesia involving the upper right canine and first premolar were evaluated. At the end of each injection, volunteers rated the pain on injection on a visual analogue scale (VAS). Both ropivacaine and adrenaline, and lignocaine with adrenaline, were more successful anaesthetic agents than liposome-encapsulated ropivacaine or plain ropivacaine (p < 0.05). There were no significant differences among the anaesthetic preparations in the onset of pulpal anaesthesia. Ropivacaine and adrenaline and lignocaine and adrenaline gave a significantly longer duration of pulpal anaesthesia. VAS showed no significant differences among the groups tested. The results showed that encapsulation of liposome did not improve the anaesthetic efficacy of ropivacaine.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sisk A.L.
        Long-acting local anesthetics in dentistry.
        Anesth Prog. 1992; 39: 53-60
        • Malamed S.F.
        Local anesthetics: dentistry's most important drugs, clinical update 2006.
        J Calif Dent Assoc. 2006; 34: 971-976
        • Marković A.B.
        • Todorović L.
        Postoperative analgesia after lower third molar surgery: contribution of the use of long-acting local anesthetics, low-power laser, and diclofenac.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102: e4-e8
        • Akerman B.
        • Hellberg I.B.
        • Trossvik C.
        Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA 103).
        Acta Anaesthesiol Scand. 1988; 3: 571-578
        • Zink W.
        • Graf B.M.
        The toxicity of local anesthetics: the place of ropivacaine and levobupivacaine.
        Curr Opin Anaesthesiol. 2008; 21: 645-650
        • Kennedy M.
        • Reader A.
        • Beck M.
        • Weaver J.
        Anesthetic efficacy of ropivacaine in maxillary anterior infiltration.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 91: 406-412
        • Ernberg M.
        • Kopp S.
        Ropivacaine for dental anesthesia: a dose-finding study.
        J Oral Maxillofac Surg. 2002; 60: 1004-1011
        • Axelsson S.
        • Isacsson G.
        The efficacy of ropivacaine as a dental local anaesthetic.
        Swed Dent J. 2004; 28: 85-91
        • El-Sharrawy E.
        • Yagiela J.A.
        Anesthetic efficacy of different ropivacaine concentrations for inferior alveolar nerve block.
        Anesth Prog. 2006; 53: 3-7
        • Buric N.
        The assessment of anesthetic efficacy of ropivacaine in oral surgery.
        N Y State Dent J. 2006; 72: 36-39
        • Boogaerts J.
        • Declercq A.
        • Lafont N.
        • Benameur H.
        • Akodad E.M.
        • Dupont J.C.
        • et al.
        Toxicity of bupivacaine encapsulated into liposomes and injected intravenously: comparison with plain solutions.
        Anesth Analg. 1993; 76: 553-555
        • Grant G.J.
        • Barenholz Y.
        • Bolotin E.M.
        • Bansinath M.
        • Turndorf H.
        • Piskoun B.
        • et al.
        A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia.
        Anesthesiology. 2004; 101: 133-137
        • Cereda C.M.
        • Brunetto G.B.
        • de Araújo D.R.
        • de Paula E.
        Liposomal formulations of prilocaine, lidocaine and mepivacaine prolong analgesic duration.
        Can J Anaesth. 2006; 53: 1092-1097
        • de Araujo D.R.
        • Cereda C.M.
        • Brunetto G.B.
        • Vomero V.U.
        • Pierucci A.
        • Neto H.S.
        • et al.
        Pharmacological and local toxicity studies of a liposomal formulation for the novel local anaesthetic ropivacaine.
        J Pharm Pharmacol. 2008; 60: 1449-1457
        • Tofoli G.R.
        • Cereda C.M.
        • Groppo F.C.
        • Volpato M.C.
        • Franz-Montan M.
        • Ranali J.
        • et al.
        Efficacy of liposome-encapsulated mepivacaine for infiltrative anesthesia in volunteers.
        J Liposome Res. 2011; 21: 88-94
        • Franz-Montan M.
        • Bergamaschi C.
        • de Paula E.
        • Groppo F.C.
        • Ranali J.
        • Fraceto L.F.
        • et al.
        Pharmacokinetic profile of liposome-encapsulated ropivacaine after maxillary infiltration anaesthesia.
        J Braz Chem Soc. 2010; 21: 1945-1951
        • Franz-Montan M.
        • Silva A.L.
        • Cogo K.
        • Bergamaschi C.
        • Volpato M.C.
        • Ranali J.
        • et al.
        Efficacy of 1% ropivacaine gel for topical anesthesia of human oral mucosa.
        Quintessence Int. 2007; 38: 601-606
        • Certosimo A.J.
        • Archer R.D.
        A clinical evaluation of the electric pulp tester as an indicator of local anesthesia.
        Oper Dent. 1996; 21: 25-30
        • Franz-Montan M.
        • Silva A.L.
        • Cogo K.
        • Bergamaschi C. de C.
        • Volpato M.C.
        • Ranali J.
        • et al.
        Liposome-encapsulated ropivacaine for topical anesthesia of human oral mucosa.
        Anesth Analg. 2007; 104: 1528-1533
        • Oliveira N.E.
        • Lima Filho N.S.
        • Lima E.G.
        • Vasquez E.C.
        Effects of regional anesthesia with ropivacaine on arterial pressure and heart rate in healthy subjects.
        Eur J Oral Sci. 2006; 114: 27-32
        • Wienzek H.
        • Freise H.
        • Giesler I.
        • Van Aken H.K.
        • Sielenkaemper A.W.
        Altered blood flow in terminal vessels after local application of ropivacaine and prilocaine.
        Reg Anesth Pain Med. 2007; 32: 233-239
        • Barenholz Y.
        Relevancy of drug loading to liposomal formulation therapeutic efficacy.
        J Liposome Res. 2003; 13: 1-8
        • Meechan J.G.
        • Day P.F.
        A comparison of intraoral injection discomfort produced by plain and epinephrine-containing lidocaine local anesthetic solutions: a randomized, double-blind, split-mouth, volunteer investigation.
        Anesth Prog. 2002; 49: 44-48
        • Oikarinen V.J.
        • Ylipaavalniemi P.
        • Evers H.
        Pain and temperature sensations related to local analgesia.
        Int J Oral Surg. 1975; 4: 151-156